H-SPAN Summit D.C. 2026 | A Conversation with CMS about the Longevity Dividend

Moderator: Dylan Livingston Guests: Stephanie Carlton, Mehmet Oz Medicare and Medicaid cover the population that stands to gain most from geroscience, and CMS decisions on coverage and payment ultimately determine whether an approved therapy reaches patients. This conversation with agency leadership takes up the longevity dividend directly: what compressing morbidity would mean for federal health spending, how CMS evaluates prevention when the savings arrive years later, and where the agency sees room to move.